High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer
Kotz, K.W.; Schilder, R.J.
Seminars in Oncology 22(3): 250-262
1995
ISSN/ISBN: 0093-7754 PMID: 7777869 Document Number: 446454
Document emailed within 1 workday
Related Documents
Bertucci, F.; Viens, P.; Gravis, G.; Blaise, D.; Faucher, C.; Oziel-Taoeb, S.; Bardou, V.J.; Jacquemier, J.; Delpero, J.R.; Maraninchi, D. 1999: High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution Anticancer Research 19(2b): 1455-1461Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Fennelly, D.W.; Aghajanian, C.; Shapiro, F.; O'Flaherty, C.; O'Connor, K.; Curtin, J.P.; Crown, J.P.; Hoskins, W.J.; Spriggs, D.R. 1997: Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Sola, C.; Mendoza, L.; Amill, B.; Mesía, R.; Rueda, A.; Alonso, M.C.; Ojeda, B.; Artigas, V.; Tugues, D.; García, J. 1995: Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery Revista Clinica Espanola 195(2): 83-88
Panici, P.B.; Scambia, G.; Baiocchi, G.; Laurelli, G.; Greggi, S.; Battaglia, F.; Ragusa, G.; Salerno, G.; Gallo, A.; Cento, R. 1990: Rationale for very high-dose chemotherapy with peripheral blood stem cell support in advanced ovarian cancer Haematologica 75(Suppl 1): 87-89
Abrahamsen, J.F.; Kristoffersen, E.K.; Hervig, T.; Ekanger, R.; Nesthus, I.; Ulvestad, E. 2000: High dose chemotherapy with autologous stem cell support in cancer patients Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(13): 1523-1528
Kaminer, L.S.; Williams, S.F.; Beschorner, J.; O'Brien, S.; Golick, J.; Bitran, J.D. 1989: High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma Bone Marrow Transplantation 4(4): 359-362
Ziske, C.; Gorschlüter, M.; Mey, U.; Offergeld, R.; Glasmacher, A.; Schmidt-Wolf, I.G.H. 2002: Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer Anticancer Research 22(6b): 3723-3726
Yen, M.L.; Chen, Y.C.; Lin, M.T.; Liu, M.C.; Tang, J.L.; Wang, C.H.; Hsieh, C.Y. 1992: High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: preliminary report of a new strategy Transplantation Proceedings 24(4): 1533-1535
Meropol, N.J.; Overmoyer, B.A.; Stadtmauer, E.A. 1992: High-dose chemotherapy with autologous stem cell support for breast cancer Oncology 6(12): 53-60; 63; Discussion: 63-4 69
Scheid, C.; Pettengell, R.; Ghielmini, M.; Radford, J.A.; Morgenstern, G.R.; Stern, P.L.; Crowther, D. 1995: Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma Bone Marrow Transplantation 15(6): 901-906
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Fujimoto, N.; Ueoka, H.; Kiura, K.; Tabata, M.; Bessho, A.; Takata, I.; Sunami, K.; Hiramatsu, Y.; Ikeda, K.; Tanimoto, M.; Harada, M. 2003: Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer Anticancer Research 23(5b): 4229-4232
Antimi, M. 1998: High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives La Clinica Terapeutica 149(921): 7-9
Sobecks, R.M.; Vogelzang, N.J. 1999: High-dose chemotherapy with autologous stem-cell support for germ cell tumors: a critical review Seminars in Oncology 26(1): 106-118
Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W. 2000: Phase Ii study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer European Journal of Gynaecological Oncology 21(6): 610-612
Rosenblatt, K.A.; Thomas, D.B.; Noonan, E.A. 1992: High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives European Journal of Cancer 28a (11): 1872-1876
Rosenblatt, K.A.; Thomas, D.B.; Noonan, E.A. 1992: High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives European Journal of Cancer 28a (11): 1872-1876
Gaspar, N.; Boudou, P.; Haroche, J.; Wechsler, B.; Van Den Neste, E.; Hoang-Xuan, K.; Amoura, Z.; Guillevin, R.; Savatovski, J.; Azar, N.; Piette, J-Charles.; Leblond, Véronique. 2006: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement Haematologica 91(8): 1121-1125
van den Berkmortel, F.; Gidding, C.; De Kanter, M.; Punt, C.J.A. 2006: Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours Anticancer Research 26(1b): 729-733